DR. DAVID L BROWN, M.D.
Medical Practice at 9 Ave, Auburn, WA
License number
Washington MD60081780
Category
Neurology
Type
Neurology
License number
Washington MD60081780
Category
Psychiatric
Type
Sleep Medicine
License number
Washington C5267
Category
Medical Practice
Type
Specialist
License number
Washington MD60081780
Category
Medical Practice
Type
Specialist
Address
Address
34503 9Th Ave S STE 230, Auburn, WA 98003
Phone
(253) 838-3103
(253) 838-7134 (Fax)
(253) 838-7134 (Fax)
Personal information
See more information about DAVID L BROWN at radaris.comName
Address
Phone
5012 W 19Th Ave, Kennewick, WA 99338
Lynden, WA
Renton, WA
Professional information
See more information about DAVID L BROWN at trustoria.com
David L Brown, Federal Way WA
David L Brown, Federal Way WA
Specialties:
Neurologist
Address:
34503 9Th Ave S, Federal Way, WA 98003
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Sleep Medicine (Psychiatry and Neurology)
David Lee Brown, Federal Way WA
David Lee Brown, Federal Way WA
Specialties:
Neurology, Sleep Medicine, Sleep Medicine
Work:
FMG Franciscan Neurology Federal Way
34503 9Th Ave S, Federal Way, WA 98003
34503 9Th Ave S, Federal Way, WA 98003
Education:
University of Arkansas(1977)
David Brown - Auburn, WA
David Brown - Auburn, WA
Work:
West Coast Management - Renton, WA
Kohl's - Covington, WA
Supervisor ACS - Auburn, WA
Customer service supervisor
Supervisor ACS - Auburn, WA
Customer service supervisor
Annexin Derivative With Endogenous Chelation Sites
Annexin Derivative With Endogenous Chelation Sites
US Patent:
6323313, Nov 27, 2001
Filed:
Jun 1, 1999
Appl. No.:
9/324096
Inventors:
Jonathan F. Tait - Seattle WA
David S. Brown - Auburn WA
David S. Brown - Auburn WA
Assignee:
The University of Washington - Seattle WA
International Classification:
C07K 500
US Classification:
530324
Abstract:
Modified annexins having an N-terminal chelation site comprising an amino acid extension are disclosed. The amino acid extension includes an amino acid sequence X. sub. 1 -Gly-X. sub. 2, where X. sub. 1 and X. sub. 2 are selected from Gly and Cys, where at least one of X. sub. 1 or X. sub. 2 is Cys. Radionuclides are readily chelated by the modified annexins to provide radiolabeled annexins useful in imaging vascular thrombi and apoptosis in vivo.
Annexin Derivatives With Endogenous Chelation Sites
Annexin Derivatives With Endogenous Chelation Sites
US Patent:
2005009, May 5, 2005
Filed:
Dec 15, 2004
Appl. No.:
11/012708
Inventors:
Jonathan Tait - Seattle WA, US
David Brown - Auburn WA, US
David Brown - Auburn WA, US
International Classification:
A61K051/00, A61K049/00
US Classification:
424001690, 424009340, 530409000
Abstract:
Modified annexins having an N-terminal chelation site comprising an amino acid extension are disclosed. The amino acid extension includes an amino acid sequence X-Gly-X, where Xand Xare selected from Gly and Cys, where at least one of Xor Xis Cys. Radionuclides are readily chelated by the modified annexins to provide radiolabeled annexins useful in imaging vascular thrombi and apoptosis in vivo.
Annexin Derivatives With Endogenous Chelation Sites
Annexin Derivatives With Endogenous Chelation Sites
US Patent:
2002010, Aug 1, 2002
Filed:
Oct 3, 2001
Appl. No.:
09/970969
Inventors:
Jonathan Tait - Seattle WA, US
David Brown - Auburn WA, US
David Brown - Auburn WA, US
Assignee:
University of Washington
International Classification:
A61K051/00, C07K014/435
US Classification:
530/350000, 424/001570
Abstract:
Modified annexins having an N-terminal chelation site comprising an amino acid extension are disclosed. The amino acid extension includes an amino acid sequence X-Gly-X, where Xand Xare selected from Gly and Cys, where at least one of Xor Xis Cys. Radionuclides are readily chelated by the modified annexins to provide radiolabeled annexins useful in imaging vascular thrombi and apoptosis in vivo.